SlideShare uma empresa Scribd logo
1 de 51
Hypertensive Heart
Disease
By
Dr.jawhar
Lecture 3
Hypertensive Heart Disease
SYSTEMIC (LEFT-SIDED) HYPERTENSIVE HEART
DISEASE:
 Criteria for diagnosis :
(1) left ventricular hypertrophy ( concentric)
(2) history or pathologic evidence of hypertension.
 Asymptomatic and suspected only by ECG or
Echocardiographic indications of left ventricular
enlargement.
 Atrial fibrillation (owing to left atrial enlargement),
or C.H.F with cardiac dilation, or both.
 Effective control of hypertension can prevent or
lead to regression of cardiac hypertrophy and
its associated risks.
Morphology:
 Left ventricular hypertrophy .
 Left ventricular wall thickness may exceed 2 cm
and heart weight may exceed 500 gm.
 Microscopically:
o The earliest change is increase in transverse
diameter of myocytes.
o At more advanced stage cellular and nuclear
enlargement becomes more irregular with
variation in cell size , and interstitial fibrosis.
PULMONARY (RIGHT-SIDED) HYPERTENSIVE HEART
DISEASE (COR PULMONALE):
 Right ventricular ( hypertrophy, dilation, and failure )
secondary to pulmonary hypertension caused by
disorders of lungs or pulmonary vasculature .
 Those caused by diseases of left side of heart, or
congenital heart diseases are excluded.
Disorders Predisposing to Cor Pulmonale :
Diseases of Pulmonary Parenchyma :-
Chronic obstructive pulmonary disease.
Diffuse pulmonary interstitial fibrosis .
Pneumoconioses.
Diseases of Pulmonary Vessels:-
Recurrent pulmonary thromboembolism.
Primary pulmonary hypertension.
Extensive pulmonary arteritis (e.g., Wegener granulomatosis).
Disorders Affecting Chest Movement:-
Kyphoscoliosis.
Marked obesity (pickwickian syndrome).
Neuromuscular diseases.
Disorders Inducing Pulmonary Arterial Constriction:-
Metabolic acidosis.
Hypoxemia.
 Cor pulmonale may be acute or chronic,
depending on suddenness of development
of pulmonary hypertension:-
 Acute cor pulmonale: can follow massive
pulmonary embolism.
 Chronic cor pulmonale: usually secondary to
prolonged pressure overload caused by
obstruction of pulmonary arteries or arterioles.
Morphology:
 Acute cor pulmonale: marked dilation of right
ventricle without hypertrophy.
 Chronic cor pulmonale: right ventricular wall
thickens up to 1.0 cm or more, and may even
approximate that of left ventricle.
Cardiomyopathies:
 Heart disease resulting from a primary
abnormality in myocardium.
 Three patterns:
o Dilated cardiomyopathy.
o Hypertrophic cardiomyopathy.
o Restrictive cardiomyopathy.
 The dilated form is most common (90% of cases),
and the restrictive is least prevalent.
DILATED CARDIOMYOPATHY:
Also called congestive cardiomyopathy.
Causes:
 Familial (genetic) : autosomal dominant.
 Toxicities: chronic alcoholism.
 Myocarditis.
 pregnancy-associated nutritional deficiency.
 Immunologic reaction.
 In some patients: unknown ( idiopathic ).
Morphology:
 Heart is large and flabby, with dilation of all
chambers.
 Mural thrombi are common and may be a source
of thromboemboli.
 Mitral or tricuspid regurgitation results from
ventricular chambers dilation (functional
regurgitation).
 Muscle cells are attenuated, stretched, and irregular.
 Interstitial and endocardial fibrosis of variable
degree is present
Clinical Features:
 Occur at any age, but usually between 20 and 50 y’s.
 Slowly progressive signs and symptoms of CHF
such as shortness of breath, and easy fatigability.
 Secondary mitral regurgitation and abnormal
cardiac rhythms are common.
 Death is due to progressive cardiac failure or
arrhythmia and can occur suddenly.
 Embolism from dislodgment of an intracardiac
thrombus may occur.
 Cardiac transplantation is only hope.
HYPERTROPHIC CARDIOMYOPATHY :
 characterized by: myocardial hypertrophy,
abnormal diastolic filling, and in one third of cases
intermittent ventricular outflow obstruction.
Morphology:
 Massive myocardial hypertrophy without
ventricular dilation.
 disproportionate thickening of ventricular septum
as compared with free wall of left ventricle (ratio
greater than 3:1) termed asymmetrical septal
hypertrophy.
 On cross-section: ventricular cavity has
"banana-like" configuration by bulging of
ventricular septum into lumen.
 Microscopically:
(1) Extensive myocyte hypertrophy with
transverse myocyte diameters greater than 40 µm
(normal 15 µm).
(2) Haphazard disarray of myocytes.
(3) Interstitial and replacement fibrosis.
Hypertensive hd, and cardiomyopathy 3
Pathogenesis:
 H.C.M caused by a mutation in any one of
several genes that encode proteins that are
part of sarcomere.
 Sarcomere is the contractile unit of cardiac and
skeletal muscle.
 Most cases are familial and pattern of transmission
is autosomal dominant with variable expression.
 Remaining cases appear to be sporadic.
 Mutations are found in at least 12 sarcomeric genes.
 Including: β-myosin heavy chain (β-MHC),
cardiac troponinT, α-tropomyosin, and
myosin-binding protein C (MYBP-C).
 Of these, mutation in β-MHC gene is most common .
Clinical Features:
 Impaired diastolic filling of massively
hypertrophied left ventricle.
 25% of patients have dynamic obstruction to
left ventricular outflow.
 Limitation of cardiac output and secondary
increase in pulmonary venous pressure cause
exertional dyspnea.
 Harsh systolic ejection murmur, caused by
ventricular outflow obstruction .
 Owing to massive hypertrophy: myocardial ischemia
commonly results, even in absence of concomitant
CAD, and thus anginal pain is frequent.
 The major clinical problems in H.C.M are:
o atrial fibrillation with mural thrombus formation ,
and possibly embolization.
o infective endocarditis of mitral valve.
o intractable cardiac failure.
o ventricular arrhythmias , and sudden death.
 Hypertrophic cardiomyopathy is one of the most
common causes of sudden, otherwise unexplained,
death in young athletes.
RESTRICTIVE CARDIOMYOPATHY :
 Decrease in ventricular compliance, resulting in
impaired ventricular filling during diastole.
 The contractile (systolic) function of left ventricle
is usually unaffected.
 Idiopathic ; or associated with distinct diseases
that affect myocardium: radiation fibrosis,
amyloidosis, sarcoidosis, or metastatic tumor.
Morphology:
 Ventricles are of normal size or slightly enlarged.
 Cavities are not dilated, and myocardium is firm.
 Microscopically: patchy or diffuse interstitial fibrosis,
which can vary from minimal to extensive.
amorphous deposits of pale pink material between myocardial fibers.
This is characteristic for amyloid. Amyloidosis is a cause for restrictive cardiomyopathy.
Valvular Heart Disease:
 Valvular involvement by disease causes stenosis,
insufficiency (regurgitation or incompetence), or both.
 Stenosis is failure of a valve to open completely,
thereby impeding forward flow.
 Insufficiency, in contrast, results from failure of a valve
to close completely, thereby allowing reversed flow.
 Valvular abnormalities may be caused by congenital
disorders , or by a variety of acquired diseases.
 The most important causes of acquired heart valve
diseases are:
VALVULAR DEGENERATION CAUSED BY CALCIFICATION :
 due to calcific deposits (composed of calcium phosphate
mineral).
 The most frequent calcific valvular diseases are:-
Calcific Aortic Stenosis:
It is the consequence of calcification owing to progressive
and advanced age-associated "wear and tear“ injury
Morphology:
The morphologic hallmark of calcific aortic stenosis is
heaped-up calcified masses within the aortic cusps.
( a heavily calcified aortic valve removed at the time of surgical valve replacement )
Clinical Features:
 obstruction to left ventricular outflow leads to
gradually increasing pressure gradient across the
calcified valve.
 cardiac output is maintained by development of
concentric left ventricular (pressure overload)
hypertrophy.
 The hypertrophied myocardium tends to be ischemic
and angina pectoris may appear.
 There may be impairment of both systolic and diastolic
myocardial function, with symptoms of CHF.
 such patients require prompt relief of obstruction by
surgical valve replacement.
Mitral Annular Calcification:
 Degenerative calcific deposits can develop in fibrous
ring (annulus) of mitral valve.
 The process generally does not affect valvular function.
 however, it may lead either to:
o regurgitation by interfering with systolic contraction of
mitral valve ring.
o stenosis by impairing opening of mitral leaflets.
o arrhythmias and occasionally sudden death by calcium
deposits penetrating sufficiently deeply to impinge on
atrioventricular conduction system.
Mitral annulus calcification: pathology specimen
This autopsy specimen demonstrates thickened mitral valve leafelts, with marked stenosis.
The mitral annulus calcification is seen as pale white 'lumps' under the endothelium around
the margins of the valve
MYXOMATOUS DEGENERATION OF MITRAL VALVE
(MITRAL VALVE PROLAPSE):
 one or both mitral leaflets are "floppy" and prolapse, or
balloon back into left atrium during systole.
 most often in young women.
 Usually an incidental finding on physical examination.
 may lead to serious complications in minority of cases.
Morphology:
 ballooning (hooding) of mitral leaflets.
 leaflets are often enlarged, redundant, thick, and
rubbery.
 Chordae tendineae are elongated, thinned, and
occasionally ruptured.
Slide Description: This is floppy mitral valve seen from above (left).
Note also the thickened, distorted tricuspid valve, probably
rheumatic in origin.
Pathogenesis:
 there is developmental defect of connective tissue,
possibly systemic.
 So it is a common feature of Marfan syndrome (caused
by mutations in gene encoding fibrillin-1 )
Clinical Features:
 Most patients are asymptomatic, discovered on routine
examination by presence of a midsystolic click .
 when mitral regurgitation occurs, there is a late systolic
or sometimes holosystolic murmur.
 A minority of patients have chest pain mimicking
angina, dyspnea, and fatigue.
RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE :
 Rheumatic fever ( RF ) is an acute, immunologically
mediated, multisystem inflammatory disease that
occurs a few weeks following an episode of group A
streptococcal pharyngitis.
 Acute rheumatic carditis during active phase of RF may
progress to chronic rheumatic heart disease (RHD).
 The most important consequence of RV is chronic
valvular deformities, characterized principally by
deforming fibrotic valvular disease (particularly mitral
stenosis)
Morphology:
 During acute RF, focal inflammatory lesions are found
within heart called Aschoff bodies ( rheumatic
granuloma ).
 Aschoff bodies consist of foci of degenerated collagen
surrounded by lymphocytes (primarily T cells),
occasional plasma cells, and plump macrophages called
Anitschkow cells (pathognomonic for RF).
 Anitschkow cells have abundant cytoplasm and central
round-to-ovoid nuclei in which the chromatin is
disposed as a central, slender, wavy ribbon (hence the
designation "caterpillar cells").
 Some of larger macrophages become multinucleated to
form Aschoff giant cells.
Hypertensive hd, and cardiomyopathy 3
Hypertensive hd, and cardiomyopathy 3
 Aschoff bodies may be found in any of three layers of
heart ( pericardium, myocardium, or endocardium )
hence the lesion is called pancarditis.
 involvement of endocardium and left-sided valves
results in fibrinoid necrosis within cusps or along
chordae tendineae .
 on which sit small (1- to 2-mm) vegetations (verrucae)
along lines of closure.
 These irregular, warty projections (verrucae ) arise from
precipitation of fibrin at sites of erosion, related to
underlying inflammation and collagen degeneration.
Hypertensive hd, and cardiomyopathy 3
 Chronic RHD is characterized by organization of acute
inflammation and subsequent fibrosis.
 valvular leaflets become thickened and retracted,
causing permanent deformity.
 Microscopically there is diffuse fibrosis and often
neovascularization that obliterate the originally
avascular leaflet architecture.
In chronic rheumatic mitral valvulitis the valve leaflets and chordae tendineae are
thick, rigid, and interadherent.
Pathogenesis:
 acute rheumatic fever is a hypersensitivity reaction
induced by group A streptococci.
 antibodies directed against M proteins of certain strains
of streptococci cross-react with glycoprotein antigens
in heart, joints, and other tissues.
 The onset of symptoms 2 to 3 weeks after infection and
the absence of streptococci from the lesions support
the concept that RF results from an immune response
against the offending bacteria.
Clinical Features:
 RF is characterized by major manifestations:
(1) migratory polyarthritis of large joints,
(2) carditis.
(3) subcutaneous nodules.
(4) erythema marginatum of skin.
(5) Sydenham chorea ( neurologic disorder with
involuntary purposeless, rapid movements ).
 The diagnosis is established by so-called Jones criteria:
the presence of two of major manifestations, or one
major and two minor manifestations ( fever, arthralgia,
or elevated blood levels of acute phase reactants-CRP).
 Acute RF appears most often in children between
ages 5 and 15, but about 20% of first attacks occur
in middle to later life.
 Although pharyngeal cultures for streptococci are
negative by the time the illness begins, antibodies
to one or more streptococcal enzymes, such as
streptolysin O and DNAse B are present and can be
detected in sera of most patients.
INFECTIVE ENDOCARDITIS (IE ):
 is characterized by colonization or invasion of heart
valves or endocardium by a microbe, leading to
formation of bulky friable vegetations composed of
thrombotic debris and organisms, often associated with
destruction of underlying cardiac tissues.
 Although fungi, rickettsiae (Q fever), and chlamydiae
have been responsible for these infections, most cases
are bacterial (bacterial endocarditis).
Etiology and Pathogenesis:
 classified on clinical grounds into acute and subacute
forms.
 Acute endocarditis: destructive infection of a previously
normal heart valve with a highly virulent organism
(S. aureus ) as in intravenous drug abusers.
 Subacute endocarditis: organisms of low virulence
(Streptococcus viridans )can cause infection in
a previously deformed valves.
 Prosthetic valve endocarditis is caused most commonly
by coagulase-negative staphylococci ( S. epidermidis).
Morphology:
 In both subacute and acute forms friable, bulky, and
destructive vegetations containing fibrin, inflammatory
cells, and bacteria or other organisms are present on
heart valves .
 The aortic and mitral valves are most common sites of
infection
 The vegetations may be single or multiple and may
involve more than one valve.
 Vegetations sometimes erode into underlying
myocardium to produce an abscess cavity (ring abscess).
 Fungal endocarditis tends to cause large vegetations
than does bacterial infection.
 Systemic emboli may occur because of friable nature of
vegetations, and may cause infarcts in brain, kidneys,
myocardium, and other tissues.
 Because the embolic fragments contain large numbers of
virulent organisms, abscesses often develop at sites of
such infarcts (septic infarcts).
 With passage of time, fibrosis, calcification, and chronic
inflammatory infiltrate may develop.
Mitral vegetation in a 78-year-old man with infective endocarditis.
Intraoperative photograph shows a large vegetation (arrow) adhering to posterior
mitral leaflet (arrowhead).
Diagnostic Criteria for Infective Endocarditis
Pathologic Criteria:
Microorganisms, demonstrated by culture or histologic examination, in a vegetation, embolus from a
vegetation, or intracardiac abscess.
Clinical Criteria:
Major:-
Positive blood culture(s) indicating characteristic organism.
Echocardiographic findings ; including valve-related or implant-related mass or abscess, or partial
separation of artificial valve.
New valvular regurgitation.
Minor:-
Predisposing heart lesion or intravenous drug use.
Fever.
Vascular lesions ; including arterial petechiae, subungual/splinter hemorrhages , emboli, septic infarcts,
mycotic aneurysm, intracranial hemorrhage, Janeway lesions.
Immunologic phenomena ; including glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor.
Microbiologic evidence ; including single culture showing uncharacteristic organism.
Echocardiographic findings consistent with but not diagnostic of endocarditis ; including new valvular
regurgitation, pericarditis.
 Diagnosis by Duke Criteria, requires either pathologic or
clinical criteria; if clinical criteria are used, 2 major, or 1
major + 3 minor, or 5 minor criteria are required for
diagnosis.
 Janeway lesions are small erythematous lesions on
palms and soles.
 Osler nodes are small subcutaneous nodules in pulp of
digits.
 Roth spots are oval retinal hemorrhages with pale
centers.
 Prevention of IE is done by prophylactic use of
antibiotics in patient with cardiac anomaly or artificial
valve who is about to have a dental, surgical, or other
invasive procedure.
Hypertensive hd, and cardiomyopathy 3
The Roth Spot subungual/splinter hemorrhages
Nonbacterial Thrombotic Endocarditis (NBTE):
 NBTE is characterized by deposition of small masses
(1 to 5 mm) of fibrin, platelets, and other blood
components on leaflets of cardiac valves.
 In contrast to vegetations of IE, the valvular lesions of
NBTE are nondestructive , sterile and do not contain
microorganisms.
 NBTE is often encountered in debilitated patients,
such as those with cancer or sepsis ( hence previously
termed marantic endocarditis).
 NBTE may producing emboli and resultant infarcts in
brain, heart, or elsewhere.
THANK YOU

Mais conteúdo relacionado

Mais procurados

Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathyNizam Uddin
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseasesikramdr01
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisDrAnsuman Dash
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditishodmedicine
 
Valvular heart disease
Valvular heart diseaseValvular heart disease
Valvular heart diseaseAmir Mahmoud
 
Mitral valve anatomy - ppt by kunwar sidharth
Mitral valve    anatomy - ppt by kunwar sidharthMitral valve    anatomy - ppt by kunwar sidharth
Mitral valve anatomy - ppt by kunwar sidharthkunwar sidharth
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart diseasehus100
 
Diseases of the aorta
Diseases of the aortaDiseases of the aorta
Diseases of the aortaFuad Farooq
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisVijay Anand
 
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathyFuad Farooq
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathiesAbhay Mange
 
Ischemic heart diseae lecture
Ischemic heart diseae lectureIschemic heart diseae lecture
Ischemic heart diseae lecturememoalawad
 
RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE
 RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE
RHEUMATIC FEVER AND RHEUMATIC HEART DISEASEANILKUMAR BR
 

Mais procurados (20)

Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
 
Aortic stenosis for post graduates
Aortic stenosis for post graduatesAortic stenosis for post graduates
Aortic stenosis for post graduates
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseases
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Chronic Stable Angina- Diagnosis & management
Chronic Stable Angina- Diagnosis & managementChronic Stable Angina- Diagnosis & management
Chronic Stable Angina- Diagnosis & management
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditis
 
Valvular heart disease
Valvular heart diseaseValvular heart disease
Valvular heart disease
 
Mitral valve anatomy - ppt by kunwar sidharth
Mitral valve    anatomy - ppt by kunwar sidharthMitral valve    anatomy - ppt by kunwar sidharth
Mitral valve anatomy - ppt by kunwar sidharth
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart disease
 
Diseases of the aorta
Diseases of the aortaDiseases of the aorta
Diseases of the aorta
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Hypertension & heart
Hypertension & heartHypertension & heart
Hypertension & heart
 
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathy
 
Aortic stenosis- Dr Shaz Pamangadan
Aortic stenosis- Dr Shaz PamangadanAortic stenosis- Dr Shaz Pamangadan
Aortic stenosis- Dr Shaz Pamangadan
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathies
 
Abdominal Aortic Aneurysm
Abdominal Aortic AneurysmAbdominal Aortic Aneurysm
Abdominal Aortic Aneurysm
 
Ischemic heart diseae lecture
Ischemic heart diseae lectureIschemic heart diseae lecture
Ischemic heart diseae lecture
 
RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE
 RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE
RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE
 

Destaque

hypertensive heart disease
hypertensive heart diseasehypertensive heart disease
hypertensive heart diseasechamonina
 
1. heart pathology; heart failure
1. heart pathology; heart failure1. heart pathology; heart failure
1. heart pathology; heart failureKrishna Tadepalli
 
4. heart pathology; hypertensive heart diseases
4. heart pathology; hypertensive heart diseases4. heart pathology; hypertensive heart diseases
4. heart pathology; hypertensive heart diseasesKrishna Tadepalli
 
7. heart pathology; myocadial diseases
7. heart pathology; myocadial diseases7. heart pathology; myocadial diseases
7. heart pathology; myocadial diseasesKrishna Tadepalli
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart diseaseimrana tanvir
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart diseaseRISHIKESAN K V
 
Pathology of CVD
Pathology of CVDPathology of CVD
Pathology of CVDmgsonline
 
Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)Louie Ray
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Toufiqur Rahman
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSIONHIRANGER
 
Hypertension power point
Hypertension power pointHypertension power point
Hypertension power pointkreid204
 

Destaque (13)

hypertensive heart disease
hypertensive heart diseasehypertensive heart disease
hypertensive heart disease
 
1. heart pathology; heart failure
1. heart pathology; heart failure1. heart pathology; heart failure
1. heart pathology; heart failure
 
4. heart pathology; hypertensive heart diseases
4. heart pathology; hypertensive heart diseases4. heart pathology; hypertensive heart diseases
4. heart pathology; hypertensive heart diseases
 
7. heart pathology; myocadial diseases
7. heart pathology; myocadial diseases7. heart pathology; myocadial diseases
7. heart pathology; myocadial diseases
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart disease
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart disease
 
Hypertensive heart disease
Hypertensive heart diseaseHypertensive heart disease
Hypertensive heart disease
 
Pathology of Hypertension
Pathology of HypertensionPathology of Hypertension
Pathology of Hypertension
 
Pathology of CVD
Pathology of CVDPathology of CVD
Pathology of CVD
 
Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)Cardiovascular Pathology (part 1)
Cardiovascular Pathology (part 1)
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
 
Hypertension power point
Hypertension power pointHypertension power point
Hypertension power point
 

Semelhante a Hypertensive hd, and cardiomyopathy 3

Pericardial dis.&cardiactumors 5
Pericardial dis.&cardiactumors 5Pericardial dis.&cardiactumors 5
Pericardial dis.&cardiactumors 5Forensic Pathology
 
Cardiovascular system pathology
Cardiovascular system pathologyCardiovascular system pathology
Cardiovascular system pathologyRemix education
 
3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptxmariaidrees3
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
CardiomyopathiesMilDoc
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathyrod prasad
 
Hypertrophic obstructive cardiomyopathy
Hypertrophic obstructive cardiomyopathyHypertrophic obstructive cardiomyopathy
Hypertrophic obstructive cardiomyopathyDhanesh Bhardwaj
 
VALVULAR DISEASES & DEFORMITIES.pptx
VALVULAR DISEASES & DEFORMITIES.pptxVALVULAR DISEASES & DEFORMITIES.pptx
VALVULAR DISEASES & DEFORMITIES.pptxSAMOEINESH
 
Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology Areej Abu Hanieh
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.pptAmareDejene
 
cardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptxcardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptxAbdirisaqJacda1
 
hypertrophic myocardium.pptx
hypertrophic myocardium.pptxhypertrophic myocardium.pptx
hypertrophic myocardium.pptxRitik Agarsen
 
VALVULAR HEART DISEASES.pptx
VALVULAR HEART DISEASES.pptxVALVULAR HEART DISEASES.pptx
VALVULAR HEART DISEASES.pptxMaina64
 

Semelhante a Hypertensive hd, and cardiomyopathy 3 (20)

Cardiovascular system path docx
Cardiovascular system path docxCardiovascular system path docx
Cardiovascular system path docx
 
Pericardial dis.&cardiactumors 5
Pericardial dis.&cardiactumors 5Pericardial dis.&cardiactumors 5
Pericardial dis.&cardiactumors 5
 
Cardiovascular system pathology
Cardiovascular system pathologyCardiovascular system pathology
Cardiovascular system pathology
 
3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
Heart diseases
Heart diseasesHeart diseases
Heart diseases
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Cardiac tumours
Cardiac tumoursCardiac tumours
Cardiac tumours
 
Hypertrophic obstructive cardiomyopathy
Hypertrophic obstructive cardiomyopathyHypertrophic obstructive cardiomyopathy
Hypertrophic obstructive cardiomyopathy
 
VALVULAR DISEASES & DEFORMITIES.pptx
VALVULAR DISEASES & DEFORMITIES.pptxVALVULAR DISEASES & DEFORMITIES.pptx
VALVULAR DISEASES & DEFORMITIES.pptx
 
Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
 
Cardiomyopathy ppt
Cardiomyopathy pptCardiomyopathy ppt
Cardiomyopathy ppt
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Hemodynamic Disorders
Hemodynamic DisordersHemodynamic Disorders
Hemodynamic Disorders
 
Hemodynamic Disorders
Hemodynamic DisordersHemodynamic Disorders
Hemodynamic Disorders
 
6 cardiomyopathies
6 cardiomyopathies6 cardiomyopathies
6 cardiomyopathies
 
cardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptxcardiomyopathy2-230605222918-365b12c0.pptx
cardiomyopathy2-230605222918-365b12c0.pptx
 
hypertrophic myocardium.pptx
hypertrophic myocardium.pptxhypertrophic myocardium.pptx
hypertrophic myocardium.pptx
 
VALVULAR HEART DISEASES.pptx
VALVULAR HEART DISEASES.pptxVALVULAR HEART DISEASES.pptx
VALVULAR HEART DISEASES.pptx
 

Mais de Forensic Pathology (20)

Stat3 central tendency & dispersion
Stat3 central tendency & dispersionStat3 central tendency & dispersion
Stat3 central tendency & dispersion
 
Exercise 1 12 no solution
Exercise 1 12 no solutionExercise 1 12 no solution
Exercise 1 12 no solution
 
Writing a research protocol 2011
Writing a research protocol 2011Writing a research protocol 2011
Writing a research protocol 2011
 
Some statistical defenition
Some statistical defenitionSome statistical defenition
Some statistical defenition
 
Prac excises 3[1].5
Prac excises 3[1].5Prac excises 3[1].5
Prac excises 3[1].5
 
Exercise 1 12 no solution
Exercise 1 12 no solutionExercise 1 12 no solution
Exercise 1 12 no solution
 
Analysis of variance
Analysis of varianceAnalysis of variance
Analysis of variance
 
Stat6 chi square test
Stat6 chi square testStat6 chi square test
Stat6 chi square test
 
Stat5 the t test
Stat5 the t testStat5 the t test
Stat5 the t test
 
Stat3 central tendency & dispersion
Stat3 central tendency & dispersionStat3 central tendency & dispersion
Stat3 central tendency & dispersion
 
Stat 4 the normal distribution & steps of testing hypothesis
Stat 4 the normal distribution & steps of testing hypothesisStat 4 the normal distribution & steps of testing hypothesis
Stat 4 the normal distribution & steps of testing hypothesis
 
Stat 2 data presentation2
Stat 2 data presentation2Stat 2 data presentation2
Stat 2 data presentation2
 
Correlation 3rd
Correlation 3rdCorrelation 3rd
Correlation 3rd
 
Stat 1 variables & sampling
Stat 1 variables & samplingStat 1 variables & sampling
Stat 1 variables & sampling
 
Pancreas 2
Pancreas 2Pancreas 2
Pancreas 2
 
Pancreas 1
Pancreas 1Pancreas 1
Pancreas 1
 
Liver 3
Liver 3Liver 3
Liver 3
 
Liver 2
Liver 2Liver 2
Liver 2
 
Liver 1
Liver 1Liver 1
Liver 1
 
The biliary tract
The biliary tractThe biliary tract
The biliary tract
 

Último

pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 

Último (20)

pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 

Hypertensive hd, and cardiomyopathy 3

  • 2. Hypertensive Heart Disease SYSTEMIC (LEFT-SIDED) HYPERTENSIVE HEART DISEASE:  Criteria for diagnosis : (1) left ventricular hypertrophy ( concentric) (2) history or pathologic evidence of hypertension.  Asymptomatic and suspected only by ECG or Echocardiographic indications of left ventricular enlargement.
  • 3.  Atrial fibrillation (owing to left atrial enlargement), or C.H.F with cardiac dilation, or both.  Effective control of hypertension can prevent or lead to regression of cardiac hypertrophy and its associated risks. Morphology:  Left ventricular hypertrophy .  Left ventricular wall thickness may exceed 2 cm and heart weight may exceed 500 gm.
  • 4.  Microscopically: o The earliest change is increase in transverse diameter of myocytes. o At more advanced stage cellular and nuclear enlargement becomes more irregular with variation in cell size , and interstitial fibrosis.
  • 5. PULMONARY (RIGHT-SIDED) HYPERTENSIVE HEART DISEASE (COR PULMONALE):  Right ventricular ( hypertrophy, dilation, and failure ) secondary to pulmonary hypertension caused by disorders of lungs or pulmonary vasculature .  Those caused by diseases of left side of heart, or congenital heart diseases are excluded.
  • 6. Disorders Predisposing to Cor Pulmonale : Diseases of Pulmonary Parenchyma :- Chronic obstructive pulmonary disease. Diffuse pulmonary interstitial fibrosis . Pneumoconioses. Diseases of Pulmonary Vessels:- Recurrent pulmonary thromboembolism. Primary pulmonary hypertension. Extensive pulmonary arteritis (e.g., Wegener granulomatosis). Disorders Affecting Chest Movement:- Kyphoscoliosis. Marked obesity (pickwickian syndrome). Neuromuscular diseases. Disorders Inducing Pulmonary Arterial Constriction:- Metabolic acidosis. Hypoxemia.
  • 7.  Cor pulmonale may be acute or chronic, depending on suddenness of development of pulmonary hypertension:-  Acute cor pulmonale: can follow massive pulmonary embolism.  Chronic cor pulmonale: usually secondary to prolonged pressure overload caused by obstruction of pulmonary arteries or arterioles.
  • 8. Morphology:  Acute cor pulmonale: marked dilation of right ventricle without hypertrophy.  Chronic cor pulmonale: right ventricular wall thickens up to 1.0 cm or more, and may even approximate that of left ventricle.
  • 9. Cardiomyopathies:  Heart disease resulting from a primary abnormality in myocardium.  Three patterns: o Dilated cardiomyopathy. o Hypertrophic cardiomyopathy. o Restrictive cardiomyopathy.  The dilated form is most common (90% of cases), and the restrictive is least prevalent.
  • 10. DILATED CARDIOMYOPATHY: Also called congestive cardiomyopathy. Causes:  Familial (genetic) : autosomal dominant.  Toxicities: chronic alcoholism.  Myocarditis.  pregnancy-associated nutritional deficiency.  Immunologic reaction.  In some patients: unknown ( idiopathic ).
  • 11. Morphology:  Heart is large and flabby, with dilation of all chambers.  Mural thrombi are common and may be a source of thromboemboli.  Mitral or tricuspid regurgitation results from ventricular chambers dilation (functional regurgitation).  Muscle cells are attenuated, stretched, and irregular.  Interstitial and endocardial fibrosis of variable degree is present
  • 12. Clinical Features:  Occur at any age, but usually between 20 and 50 y’s.  Slowly progressive signs and symptoms of CHF such as shortness of breath, and easy fatigability.  Secondary mitral regurgitation and abnormal cardiac rhythms are common.  Death is due to progressive cardiac failure or arrhythmia and can occur suddenly.  Embolism from dislodgment of an intracardiac thrombus may occur.  Cardiac transplantation is only hope.
  • 13. HYPERTROPHIC CARDIOMYOPATHY :  characterized by: myocardial hypertrophy, abnormal diastolic filling, and in one third of cases intermittent ventricular outflow obstruction. Morphology:  Massive myocardial hypertrophy without ventricular dilation.  disproportionate thickening of ventricular septum as compared with free wall of left ventricle (ratio greater than 3:1) termed asymmetrical septal hypertrophy.
  • 14.  On cross-section: ventricular cavity has "banana-like" configuration by bulging of ventricular septum into lumen.  Microscopically: (1) Extensive myocyte hypertrophy with transverse myocyte diameters greater than 40 µm (normal 15 µm). (2) Haphazard disarray of myocytes. (3) Interstitial and replacement fibrosis.
  • 16. Pathogenesis:  H.C.M caused by a mutation in any one of several genes that encode proteins that are part of sarcomere.  Sarcomere is the contractile unit of cardiac and skeletal muscle.  Most cases are familial and pattern of transmission is autosomal dominant with variable expression.  Remaining cases appear to be sporadic.
  • 17.  Mutations are found in at least 12 sarcomeric genes.  Including: β-myosin heavy chain (β-MHC), cardiac troponinT, α-tropomyosin, and myosin-binding protein C (MYBP-C).  Of these, mutation in β-MHC gene is most common .
  • 18. Clinical Features:  Impaired diastolic filling of massively hypertrophied left ventricle.  25% of patients have dynamic obstruction to left ventricular outflow.  Limitation of cardiac output and secondary increase in pulmonary venous pressure cause exertional dyspnea.  Harsh systolic ejection murmur, caused by ventricular outflow obstruction .
  • 19.  Owing to massive hypertrophy: myocardial ischemia commonly results, even in absence of concomitant CAD, and thus anginal pain is frequent.  The major clinical problems in H.C.M are: o atrial fibrillation with mural thrombus formation , and possibly embolization.
  • 20. o infective endocarditis of mitral valve. o intractable cardiac failure. o ventricular arrhythmias , and sudden death.  Hypertrophic cardiomyopathy is one of the most common causes of sudden, otherwise unexplained, death in young athletes.
  • 21. RESTRICTIVE CARDIOMYOPATHY :  Decrease in ventricular compliance, resulting in impaired ventricular filling during diastole.  The contractile (systolic) function of left ventricle is usually unaffected.  Idiopathic ; or associated with distinct diseases that affect myocardium: radiation fibrosis, amyloidosis, sarcoidosis, or metastatic tumor.
  • 22. Morphology:  Ventricles are of normal size or slightly enlarged.  Cavities are not dilated, and myocardium is firm.  Microscopically: patchy or diffuse interstitial fibrosis, which can vary from minimal to extensive. amorphous deposits of pale pink material between myocardial fibers. This is characteristic for amyloid. Amyloidosis is a cause for restrictive cardiomyopathy.
  • 23. Valvular Heart Disease:  Valvular involvement by disease causes stenosis, insufficiency (regurgitation or incompetence), or both.  Stenosis is failure of a valve to open completely, thereby impeding forward flow.  Insufficiency, in contrast, results from failure of a valve to close completely, thereby allowing reversed flow.  Valvular abnormalities may be caused by congenital disorders , or by a variety of acquired diseases.  The most important causes of acquired heart valve diseases are:
  • 24. VALVULAR DEGENERATION CAUSED BY CALCIFICATION :  due to calcific deposits (composed of calcium phosphate mineral).  The most frequent calcific valvular diseases are:- Calcific Aortic Stenosis: It is the consequence of calcification owing to progressive and advanced age-associated "wear and tear“ injury Morphology: The morphologic hallmark of calcific aortic stenosis is heaped-up calcified masses within the aortic cusps. ( a heavily calcified aortic valve removed at the time of surgical valve replacement )
  • 25. Clinical Features:  obstruction to left ventricular outflow leads to gradually increasing pressure gradient across the calcified valve.  cardiac output is maintained by development of concentric left ventricular (pressure overload) hypertrophy.  The hypertrophied myocardium tends to be ischemic and angina pectoris may appear.  There may be impairment of both systolic and diastolic myocardial function, with symptoms of CHF.  such patients require prompt relief of obstruction by surgical valve replacement.
  • 26. Mitral Annular Calcification:  Degenerative calcific deposits can develop in fibrous ring (annulus) of mitral valve.  The process generally does not affect valvular function.  however, it may lead either to: o regurgitation by interfering with systolic contraction of mitral valve ring. o stenosis by impairing opening of mitral leaflets. o arrhythmias and occasionally sudden death by calcium deposits penetrating sufficiently deeply to impinge on atrioventricular conduction system.
  • 27. Mitral annulus calcification: pathology specimen This autopsy specimen demonstrates thickened mitral valve leafelts, with marked stenosis. The mitral annulus calcification is seen as pale white 'lumps' under the endothelium around the margins of the valve
  • 28. MYXOMATOUS DEGENERATION OF MITRAL VALVE (MITRAL VALVE PROLAPSE):  one or both mitral leaflets are "floppy" and prolapse, or balloon back into left atrium during systole.  most often in young women.  Usually an incidental finding on physical examination.  may lead to serious complications in minority of cases. Morphology:  ballooning (hooding) of mitral leaflets.  leaflets are often enlarged, redundant, thick, and rubbery.  Chordae tendineae are elongated, thinned, and occasionally ruptured.
  • 29. Slide Description: This is floppy mitral valve seen from above (left). Note also the thickened, distorted tricuspid valve, probably rheumatic in origin.
  • 30. Pathogenesis:  there is developmental defect of connective tissue, possibly systemic.  So it is a common feature of Marfan syndrome (caused by mutations in gene encoding fibrillin-1 ) Clinical Features:  Most patients are asymptomatic, discovered on routine examination by presence of a midsystolic click .  when mitral regurgitation occurs, there is a late systolic or sometimes holosystolic murmur.  A minority of patients have chest pain mimicking angina, dyspnea, and fatigue.
  • 31. RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE :  Rheumatic fever ( RF ) is an acute, immunologically mediated, multisystem inflammatory disease that occurs a few weeks following an episode of group A streptococcal pharyngitis.  Acute rheumatic carditis during active phase of RF may progress to chronic rheumatic heart disease (RHD).  The most important consequence of RV is chronic valvular deformities, characterized principally by deforming fibrotic valvular disease (particularly mitral stenosis)
  • 32. Morphology:  During acute RF, focal inflammatory lesions are found within heart called Aschoff bodies ( rheumatic granuloma ).  Aschoff bodies consist of foci of degenerated collagen surrounded by lymphocytes (primarily T cells), occasional plasma cells, and plump macrophages called Anitschkow cells (pathognomonic for RF).  Anitschkow cells have abundant cytoplasm and central round-to-ovoid nuclei in which the chromatin is disposed as a central, slender, wavy ribbon (hence the designation "caterpillar cells").  Some of larger macrophages become multinucleated to form Aschoff giant cells.
  • 35.  Aschoff bodies may be found in any of three layers of heart ( pericardium, myocardium, or endocardium ) hence the lesion is called pancarditis.  involvement of endocardium and left-sided valves results in fibrinoid necrosis within cusps or along chordae tendineae .  on which sit small (1- to 2-mm) vegetations (verrucae) along lines of closure.  These irregular, warty projections (verrucae ) arise from precipitation of fibrin at sites of erosion, related to underlying inflammation and collagen degeneration.
  • 37.  Chronic RHD is characterized by organization of acute inflammation and subsequent fibrosis.  valvular leaflets become thickened and retracted, causing permanent deformity.  Microscopically there is diffuse fibrosis and often neovascularization that obliterate the originally avascular leaflet architecture. In chronic rheumatic mitral valvulitis the valve leaflets and chordae tendineae are thick, rigid, and interadherent.
  • 38. Pathogenesis:  acute rheumatic fever is a hypersensitivity reaction induced by group A streptococci.  antibodies directed against M proteins of certain strains of streptococci cross-react with glycoprotein antigens in heart, joints, and other tissues.  The onset of symptoms 2 to 3 weeks after infection and the absence of streptococci from the lesions support the concept that RF results from an immune response against the offending bacteria.
  • 39. Clinical Features:  RF is characterized by major manifestations: (1) migratory polyarthritis of large joints, (2) carditis. (3) subcutaneous nodules. (4) erythema marginatum of skin. (5) Sydenham chorea ( neurologic disorder with involuntary purposeless, rapid movements ).  The diagnosis is established by so-called Jones criteria: the presence of two of major manifestations, or one major and two minor manifestations ( fever, arthralgia, or elevated blood levels of acute phase reactants-CRP).
  • 40.  Acute RF appears most often in children between ages 5 and 15, but about 20% of first attacks occur in middle to later life.  Although pharyngeal cultures for streptococci are negative by the time the illness begins, antibodies to one or more streptococcal enzymes, such as streptolysin O and DNAse B are present and can be detected in sera of most patients.
  • 41. INFECTIVE ENDOCARDITIS (IE ):  is characterized by colonization or invasion of heart valves or endocardium by a microbe, leading to formation of bulky friable vegetations composed of thrombotic debris and organisms, often associated with destruction of underlying cardiac tissues.  Although fungi, rickettsiae (Q fever), and chlamydiae have been responsible for these infections, most cases are bacterial (bacterial endocarditis).
  • 42. Etiology and Pathogenesis:  classified on clinical grounds into acute and subacute forms.  Acute endocarditis: destructive infection of a previously normal heart valve with a highly virulent organism (S. aureus ) as in intravenous drug abusers.  Subacute endocarditis: organisms of low virulence (Streptococcus viridans )can cause infection in a previously deformed valves.  Prosthetic valve endocarditis is caused most commonly by coagulase-negative staphylococci ( S. epidermidis).
  • 43. Morphology:  In both subacute and acute forms friable, bulky, and destructive vegetations containing fibrin, inflammatory cells, and bacteria or other organisms are present on heart valves .  The aortic and mitral valves are most common sites of infection  The vegetations may be single or multiple and may involve more than one valve.  Vegetations sometimes erode into underlying myocardium to produce an abscess cavity (ring abscess).  Fungal endocarditis tends to cause large vegetations than does bacterial infection.
  • 44.  Systemic emboli may occur because of friable nature of vegetations, and may cause infarcts in brain, kidneys, myocardium, and other tissues.  Because the embolic fragments contain large numbers of virulent organisms, abscesses often develop at sites of such infarcts (septic infarcts).  With passage of time, fibrosis, calcification, and chronic inflammatory infiltrate may develop.
  • 45. Mitral vegetation in a 78-year-old man with infective endocarditis. Intraoperative photograph shows a large vegetation (arrow) adhering to posterior mitral leaflet (arrowhead).
  • 46. Diagnostic Criteria for Infective Endocarditis Pathologic Criteria: Microorganisms, demonstrated by culture or histologic examination, in a vegetation, embolus from a vegetation, or intracardiac abscess. Clinical Criteria: Major:- Positive blood culture(s) indicating characteristic organism. Echocardiographic findings ; including valve-related or implant-related mass or abscess, or partial separation of artificial valve. New valvular regurgitation. Minor:- Predisposing heart lesion or intravenous drug use. Fever. Vascular lesions ; including arterial petechiae, subungual/splinter hemorrhages , emboli, septic infarcts, mycotic aneurysm, intracranial hemorrhage, Janeway lesions. Immunologic phenomena ; including glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor. Microbiologic evidence ; including single culture showing uncharacteristic organism. Echocardiographic findings consistent with but not diagnostic of endocarditis ; including new valvular regurgitation, pericarditis.
  • 47.  Diagnosis by Duke Criteria, requires either pathologic or clinical criteria; if clinical criteria are used, 2 major, or 1 major + 3 minor, or 5 minor criteria are required for diagnosis.  Janeway lesions are small erythematous lesions on palms and soles.  Osler nodes are small subcutaneous nodules in pulp of digits.  Roth spots are oval retinal hemorrhages with pale centers.  Prevention of IE is done by prophylactic use of antibiotics in patient with cardiac anomaly or artificial valve who is about to have a dental, surgical, or other invasive procedure.
  • 49. The Roth Spot subungual/splinter hemorrhages
  • 50. Nonbacterial Thrombotic Endocarditis (NBTE):  NBTE is characterized by deposition of small masses (1 to 5 mm) of fibrin, platelets, and other blood components on leaflets of cardiac valves.  In contrast to vegetations of IE, the valvular lesions of NBTE are nondestructive , sterile and do not contain microorganisms.  NBTE is often encountered in debilitated patients, such as those with cancer or sepsis ( hence previously termed marantic endocarditis).  NBTE may producing emboli and resultant infarcts in brain, heart, or elsewhere.